BIOLASE Inc
NASDAQ:BIOL
BIOLASE Inc
Operating Income
BIOLASE Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
BIOLASE Inc
NASDAQ:BIOL
|
Operating Income
-$17.9m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-5%
|
|
Becton Dickinson and Co
NYSE:BDX
|
Operating Income
$2.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
5%
|
|
Boston Scientific Corp
NYSE:BSX
|
Operating Income
$2.5B
|
CAGR 3-Years
46%
|
CAGR 5-Years
7%
|
CAGR 10-Years
10%
|
|
Stryker Corp
NYSE:SYK
|
Operating Income
$4.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Abbott Laboratories
NYSE:ABT
|
Operating Income
$6.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
11%
|
CAGR 10-Years
13%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Operating Income
$1.9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
9%
|
CAGR 10-Years
11%
|
See Also
What is BIOLASE Inc's Operating Income?
Operating Income
-17.9m
USD
Based on the financial report for Dec 31, 2023, BIOLASE Inc's Operating Income amounts to -17.9m USD.
What is BIOLASE Inc's Operating Income growth rate?
Operating Income CAGR 10Y
-5%
Over the last year, the Operating Income growth was 29%. The average annual Operating Income growth rates for BIOLASE Inc have been 1% over the past three years , and -5% over the past ten years .